FDA Inspection
Jubilant Draximage Inc., dba Jubilant RadiopharmaJubilant Draximage Inc., dba Jubilant Radiopharma – FDA Inspection, Dec 13, 2016
Record Details
This FDA Inspection record concerns Jubilant Draximage Inc., dba Jubilant Radiopharma, with an inspection on December 13, 2016, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- December 13, 2016
- Product Type
- Human Drugs
- Person
- Jamie L. Dion (Issuing Officer)
View Company Profile
ID · 731fbafe-5b91-4e38-a2a4-22b07997c96d
Inspection Facts
- Inspection number
- 1003944
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jubilant Draximage Inc., dba Jubilant Radiopharma
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jubilant Draximage Inc., dba Jubilant Radiopharma
- FDA Inspection 1240367 - 2024-04-23
- FDA Inspection 1171562 - 2022-06-10
- FDA Inspection 1035441 - 2017-09-08
- FDA Inspection 953137 - 2015-12-17
- FDA Inspection 850564 - 2013-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.